50 High-Yield Clinical Pharmacy One-Liners for Fast Exam Revision
NAPLEX • PEBC • BCPS • Hospital Pharmacist Job Tests • University Clinical Pharmacy Exams
Clinical Pharmacy is a high-yield subject for pharmacy licensing exams, hospital pharmacist recruitment tests, and clinical pharmacy assessments. These 50 must-know clinical pharmacy facts cover drug mechanisms of action, drug interactions, adverse drug reactions, first-line treatments, antidotes, and medication safety.
1. Cardiology & Renal Pharmacotherapy (10 Key Statements)
1. ACE inhibitors (e.g., lisinopril) can cause hyperkalemia, dry cough, and angioedema; avoid them during pregnancy.
2. ARBs (e.g., losartan) are alternatives for patients who develop ACE inhibitor–induced cough, but they can also cause hyperkalemia and are contraindicated in pregnancy.
3. Beta-blockers reduce heart rate and myocardial oxygen demand; abrupt withdrawal may precipitate rebound tachycardia, hypertension, or angina.
4. Spironolactone is a potassium-sparing mineralocorticoid receptor antagonist that can cause hyperkalemia and gynecomastia.
5. Digoxin toxicity may cause nausea, visual disturbances, and arrhythmias; digoxin immune Fab is used for life-threatening toxicity.
6. Nitroglycerin increases nitric oxide signaling and causes venodilation; combining it with sildenafil or other PDE-5 inhibitors can cause severe hypotension.
7. Warfarin inhibits vitamin K epoxide reductase (VKORC1); vitamin K reverses its effect, while major or life-threatening bleeding may require four-factor prothrombin complex concentrate (4F-PCC) plus vitamin K.
8. Unfractionated heparin enhances antithrombin activity; protamine sulfate reverses its anticoagulant effect.
9. SGLT2 inhibitors (e.g., empagliflozin) improve heart failure and kidney outcomes in appropriate patients but can cause genital mycotic infections and euglycemic diabetic ketoacidosis.
10. Loop diuretics (e.g., furosemide) inhibit the Na⁺-K⁺-2Cl⁻ cotransporter in the thick ascending limb and may cause hypokalemia, volume depletion, and ototoxicity.
2. Infectious Diseases & Antibiotics (10 Key Statements)
11. Vancomycin inhibits bacterial cell-wall synthesis by binding D-Ala-D-Ala; monitor exposure and renal function when indicated because of nephrotoxicity risk.
12. Aminoglycosides (e.g., gentamicin) inhibit the 30S ribosomal subunit and can cause nephrotoxicity and ototoxicity.
13. Fluoroquinolones inhibit DNA gyrase and topoisomerase IV and carry warnings for serious adverse effects, including tendinitis and tendon rupture.
14. Tetracyclines inhibit the 30S ribosomal subunit; iron, calcium, magnesium, and aluminum can reduce absorption by chelation.
15. Trimethoprim-sulfamethoxazole (TMP-SMX) can increase warfarin's anticoagulant effect and raise INR; it can also cause hyperkalemia.
16. Clindamycin is associated with a particularly important risk of Clostridioides difficile infection.
17. Metronidazole is active against many anaerobic bacteria and certain protozoa; it can increase the anticoagulant effect of warfarin.
18. Rifampin strongly induces several drug-metabolizing enzymes and transporters, potentially reducing the effectiveness of oral contraceptives, warfarin, and many other drugs.
19. Penicillin and other beta-lactam antibiotics inhibit bacterial cell-wall synthesis by binding penicillin-binding proteins (PBPs).
20. Vancomycin-resistant enterococci (VRE) may be treated with agents such as linezolid or daptomycin, depending on infection site, susceptibility, and patient-specific factors.
3. Endocrine & Metabolism (10 Key Statements)
21. Metformin reduces hepatic glucose production and improves insulin sensitivity; monitor renal function and consider vitamin B12 deficiency with long-term use.
22. Insulin is the most effective glucose-lowering therapy but can cause hypoglycemia and hypokalemia.
23. Sulfonylureas (e.g., glipizide) stimulate pancreatic insulin release by closing ATP-sensitive potassium channels and can cause hypoglycemia and weight gain.
24. GLP-1 receptor agonists (e.g., semaglutide) increase glucose-dependent insulin secretion, reduce appetite, and commonly cause gastrointestinal adverse effects.
25. SGLT2 inhibitors lower blood glucose by increasing urinary glucose excretion; counsel patients about dehydration, genital infections, and ketoacidosis risk, including during periods of illness or fasting.
26. Levothyroxine absorption can be reduced by calcium and iron supplements; separate administration by at least four hours.
27. Methimazole can cause agranulocytosis; patients should seek urgent assessment for fever or sore throat.
28. Systemic corticosteroids can cause hyperglycemia, osteoporosis, and adrenal suppression; prolonged therapy should generally be tapered when clinically appropriate, not stopped abruptly.
29. Desmopressin acts at V2 receptors to increase renal water reabsorption and can cause hyponatremia.
30. Bisphosphonates inhibit osteoclast-mediated bone resorption; oral formulations can cause esophageal irritation and should be taken with plain water according to product-specific administration instructions.
4. CNS & Psychiatry (10 Key Statements)
31. SSRIs (e.g., sertraline) inhibit serotonin reuptake and may cause sexual dysfunction, gastrointestinal effects, and hyponatremia.
32. Combining serotonergic drugs such as SSRIs and MAO inhibitors can cause potentially life-threatening serotonin syndrome.
33. Lithium has a narrow therapeutic index; monitor serum concentrations, renal function, thyroid function, and electrolytes.
34. Valproate can cause hepatotoxicity, pancreatitis, and major fetal harm; it is generally avoided during pregnancy when safer effective alternatives are available.
35. Carbamazepine can cause hyponatremia, serious skin reactions, and blood dyscrasias; it is also a potent enzyme inducer.
36. Phenytoin exhibits saturable metabolism, so small dose increases can produce disproportionately large increases in serum concentration.
37. Benzodiazepines enhance GABA-A receptor activity and can cause sedation, dependence, and respiratory depression, particularly with opioids or alcohol.
38. Clozapine can cause severe neutropenia, myocarditis, and dose-related seizures; follow current prescribing and blood-monitoring requirements.
39. Haloperidol blocks dopamine D2 receptors and can cause extrapyramidal symptoms and QT prolongation; neuroleptic malignant syndrome is a medical emergency.
40. Levodopa is a dopamine precursor used in Parkinson disease; carbidopa inhibits peripheral dopa decarboxylase, reducing peripheral conversion and improving levodopa availability to the CNS.
5. Toxicology, Antidotes & High-Risk Medications (10 Key Statements)
41. Paracetamol (acetaminophen) poisoning is treated with N-acetylcysteine (NAC), which replenishes glutathione and helps prevent hepatic injury.
42. Opioid overdose with respiratory depression is treated with naloxone, alongside airway and ventilatory support as needed.
43. Benzodiazepine overdose is usually managed with supportive care; flumazenil is reserved for selected cases because it may precipitate seizures or withdrawal.
44. Methanol and ethylene glycol poisoning can be treated with fomepizole, which inhibits alcohol dehydrogenase.
45. Organophosphate poisoning is treated with atropine for muscarinic manifestations and pralidoxime when indicated to reactivate acetylcholinesterase.
46. Heparin-induced thrombocytopenia (HIT) requires stopping all heparin products and initiating an appropriate non-heparin anticoagulant when indicated.
47. Malignant hyperthermia triggered by certain anesthetics or succinylcholine is treated with dantrolene and emergency supportive management.
48. Local anesthetic systemic toxicity (LAST) may cause seizures and cardiovascular collapse; treatment includes resuscitation and intravenous lipid emulsion when indicated.
49. Digoxin toxicity with life-threatening manifestations requires urgent evaluation and may require digoxin immune Fab, guided by the clinical presentation and relevant laboratory findings.
50. Medication reconciliation at admission, transfer, and discharge helps prevent medication discrepancies, omissions, duplications, and clinically significant drug interactions.
Quick Revision: Must-Know Antidotes
Drug or toxin | Antidote / reversal agent |
|---|---|
Paracetamol (acetaminophen) | N-acetylcysteine |
Opioids | Naloxone |
Unfractionated heparin | Protamine sulfate |
Warfarin with major bleeding | 4F-PCC + vitamin K |
Digoxin | Digoxin immune Fab |
Methanol / ethylene glycol | Fomepizole |
Organophosphates | Atropine + pralidoxime, when indicated |
Malignant hyperthermia | Dantrolene |
Local anesthetic systemic toxicity | IV lipid emulsion, when indicated |
Selected benzodiazepine toxicity | Flumazenil, with important precautions |
How to Use These One-Liners for Exam Preparation
First pass: Read all 50 statements to identify weak areas.
Second pass: Cover the drug names and recall the mechanism, adverse effect, or antidote.
Third pass: Turn each statement into a practice MCQ and explain why the distractors are incorrect.
Final review: Prioritize drug interactions, high-alert medications, antidotes, monitoring parameters, and boxed warnings.
Clinical reminder: These are concise revision points, not patient-specific treatment instructions. Recommendations can vary by indication, patient factors, local protocols, and updated prescribing information. For board examinations, verify details against the relevant current guidelines and drug labels.
50 High-Yield Pharmacology One-Liners for Hospital Pharmacist Job Test Preparation - Part 2
Pharmacy Exam Mock Test - Test#1
0 Comments